Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

  • Published : Dec-2018
  • Tables : 46
  • Figures : 211
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT358MR
  • Format : ppt

Key Findings

FDA Streamlines Tedious Regulatory Process of Cancer Profiling Test Authorization

The U.S. Food and Drug Administration (FDA) regulates the safety, effectiveness, sales and distribution of cancer profiling tests. On November 15, 2017, FDA authorized Memorial Sloan Kettering Cancer Center’s (MSK) IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) tumor profiling test. The test is capable of high throughput screening and identification of a higher number of mutations using biomarkers of different cancer types.

Along with this new test authorization, FDA recognized wider acceptance of cancer profiling tests for better treatment of cancer and streamlined policy framework for the efficient review process and faster availability of NGS-based cancer profiling tests. The new framework allows review of the tests by accredited third-party to reduce the test developer’s burden and streamline ensuing regulatory assessment procedures. This step has paved a way for NGS-based cancer profiling tests manufacturers to elude tedious regulatory process of authorization and faster entry to the market.

Fact.MR’s study offers incisive insights on the cancer profiling market. A summary of the report is available upon request.

global cancer profiling market size us y o y growth 2018 2028

Cancer Profiling Complements Ongoing Precision Oncology R&D Activities

Traditionally treated on the basis of body location with a one-size-fits-all approach, cancer treatment is evolved significantly wherein precision medicine has aided in better cancer management. Identification of the target mutation with cancer profiling assists in determining highly specific drug that delivers long-lasting remission and expansion of lifetime.

Personalized medicine approach in cancer treatment involves genetic information of an individual and his or her cancer cell profile. In addition, lifestyle, diet, microbiome and other information of an individual is also covered while determining the personalized treatment approach. As cancer profiling helps in delivering genetic information of cancer cells, ongoing R&D activities in the field of precision oncology present lucrative avenues for cancer profiling manufacturers.

Rising Cancer Burden Necessitates Utilization of Cancer Profiling Tests

According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is responsible for nearly 9.6 million deaths in 2018 worldwide. While major strides are being made to prevent cancer development, the medical community still need to address the estimates of new cancer cases projected in coming years. WHO estimates the global burden of cancer to have risen to 18.1 million new cases in 2018.

As the incidences of rare cancer continue to rise, personalized medicine is providing promising results in cancer treatment. Cancer profiling is aiding the personalized treatments by providing the identification of specific gene mutation and use of targeted therapies.

cancer profiling tests price analysis us unit by region

Development of Datasets and Interpretation Tools Increases Cancer Profiling Precision

Major R&D investments in the cancer profiling market are being utilized in developing platforms for genomic data and clinical information to enhance the current capabilities of genomic profiling tests for different types of cancers. The current landscape of cancer profiling is facing challenges of clinical translations due to lack of sufficient consensus for treatment development and time-consuming interpretation.

With the growing emphasis on collaborative treatment to address cancer treatment issues effectively, development of common datasets is underway which can be used to interpret cancer profiling results and improve the treatment of cancer patients.

The Blood Profiling Atlas in Cancer (BloodPAC) Consortium launched a dataset for liquid biopsies and announced public release and accessibility of initial dataset in February 2018. Max Cancer Center in India recently published development of a web-based genome profiling interpretation tool – DrAV tool. The tool provides a platform for genomic data extraction and analysis of clinical information to aid precision oncology and cancer profiling processes.

Limitations in Identification of Predictive Biomarkers to Hider Cancer Profiling Test Developments

As genomic instability and acquisition of mutations are the hallmarks of cancer, tumor heterogeneity continues to pose challenges for the identification, testing and development of cancer biomarkers. These challenges reach to drug development landscape wherein their implementation in clinical drug trials is advancing at a staggering pace.

For these reasons, the landscape of cancer therapy seeks potential strategies for the development of robust biomarkers that complements the evolving cancer alterations, thereby enabling efficient tumor biopsies using cancer profiling. While ongoing cancer therapeutic scenario is lagging behind in biomarker development, considerable investments are in pipeline and their outcome is expected to aid in the progress of cancer profiling landscape in the future.

For a detailed analysis of all the key factors in the cancer profiling market, request a sample.

Cancer Profiling Market - Competitive Landscape

In the competitive landscape of the cancer profiling market report, competition scenario of the market is explained in terms of a dashboard view of all the key players and their relative presence in the global market. The section has also identified prominent players in cancer profiling market, emerging players, mid-size players and other key players in the cancer testing market.

The section of company profiles delivers vital information such as product offerings, products in clinical trials and company developments. Few of the profiles players in the cancer profiling market report include F. Hoffmann La Roche Ltd, Illumina Inc, QIAGEN, Thermo Fisher Scientific Inc, Abbott, Nanostring Technologies Inc,  Siemens AG, HTG Molecular Diagnostics, Inc, Perkin Elmer Inc, Agilent Technologies Inc, Negenomics Laboratory Inc, Genomic Health, Biogenex and Pacific Biosciences of California, Inc.

cancer profiling competition dashboard

The cancer profiling marketplace is marked by significant investments in R&D aimed at getting clinical approvals. Multiple cancer profiling tests received FDA approvals in recent past. For instance, in November 2017, FDA approved the IMPACT developed at the Memorial Sloan Kettering Cancer Center. It is an in vitro NGS-based diagnostic test with the capacity to identify a higher number of tumor biomarkers and rapid identification of mutations in 468 unique genes.

In December 2017, FoundationOne CDx (F1CDx) genomic cancer profiling test that can identify cancer-associated alterations in 324 genes and two type of genomic signature in any solid tumor.

In August 2018, Caris Life Sciences® announced the company’s selection by the Hoosier Cancer Research Network to perform cancer profiling for a new Phase II bladder cancer clinical trial of HCRN GU16-257.

For full coverage of the competitive landscape, get in touch with our experts.

Cancer Profiling - Definition

Cancer profiling is a type of molecular profiling that provides specific information of molecular and genetic makeup of cancer tissues or cells. The information reveals abnormalities or altered levels of gene expression and assists in medical professionals to determine focused treatment of different cancer types.

Cancer Profiling Market - About the Report

Fact.MR has compiled a study on the cancer profiling and published a new report titled, “Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028.” The cancer profiling market report delivers a thorough analysis of the market that derives actionable and valuable insights.

The cancer profiling market report delivers an in-depth assessment of the market landscape that covers important dynamics such as market drivers, restraints, opportunities and trends that hold significant influence on the growth of the cancer profiling market.

The cancer profiling market report focuses on providing authentic and viable insights of the market that help readers to understand and devise strategies to enter or ensure market sustenance.

Cancer Profiling Market Structure

The cancer profiling market is studied thoroughly for different facets such as types of cancer and associated diagnostic testing methods. In addition, regulation and reimbursement scenario is also considered to design the cancer profiling market structure. The cancer profiling market is segmented on the basis of product type, indication, end user and test type. The cancer profiling market is also studied for key regions to derive global forecast.

cancer profiling market taxonomy

Based on product type, the cancer profiling market is segmented into instruments and consumables wherein instruments cover IHC, FISH, PCR instruments, DNA sequencer and fragment analyzer. The consumables segment covers reagents & kits and others ancillaries (probes, holders, etc.)

Based on indication, the cancer profiling market is segmented into breast cancer, colorectal cancer, ovarian cancer, melanoma, kidney cancer, lung cancer (including NSCLC) and rare cancer.

Hospitals, diagnostic centers, cancer research institutes and others are covered in the end-user segment of the cancer profiling market. Based on test type, the cancer profiling market is segmented into immunohistochemistry (IHC), Fluorescence in situ Hybridization (FISH), Quantitative Polymerase Chain Reaction (qPCR), Next-Generation Sequencing (NGS), Sanger sequencing and fragment analysis.

In the regional analysis, cancer epidemiology of all the key regions is thoroughly studied. Key regions included in the cancer profiling market study are North America, Latin America, Europe, CIS & Russia, Japan, APEJ and MEA. 

Cancer Profiling Market - Additional Questions Answered

In addition to the aforementioned insights, the cancer profiling market report delivers intelligent insights based on a thorough assessment of all the market facets. These insights can answer to some of the bemusing questions of the business professional interested in the cancer profiling market.

  • Which product type in the cancer profiling market will register significant demand by the end of the assessment period?
  • Which region presents considerable utilization of cancer profiling tools?
  • Among different test types, which test type will be highly sought after in the cancer profiling market during the forecast period?
  • Which end-user will register leading utilization of cancer profiling tests during the forecast period?

Cancer Profiling Market - Research Methodology

A robust research methodology is used to derive the insights and forecast of the cancer profiling market. Study of the cancer profiling market is based on a systematic approach that follows the methodology of the research.

The research entails elaborated interviews with industry savants as well as study of cancer profiling industry data. The former comprised primary research approach whereas the latter included secondary research. In the research methodology section of the cancer profiling market report, sources used to carry out primary and secondary research are also given that enable readers to determine the credibility of the data derived in the cancer profiling market report.

Request Methodology of this Report.

1. Executive Summary – Global Cancer Profiling Market
   1.1. Market Summary
   1.2. Analysis Summary
   1.3. Megatrends in Cancer Profiling Market
   1.4. Opportunity Assessment
   1.5. Wheel of Fortune Opportunity Analysis
   1.6. Fact.MR View Point

2. Market Overview
   2.1. Market Introduction
   2.2. Market Definition
   2.3. Scope of the Report

3. Market Dynamics
   3.1. Macro - Economic Factors Influencing Demand
   3.2. Key Growth Drivers and Impact Analysis
   3.3. Industry Challenges and Restraints
   3.4. Forecast Factors and Relevance of Impact

4. Key Inclusions
   4.1. Regional Pricing Analysis by Test (2017)
   4.2. Cancer Epidemiology By Region, 2017
   4.2. PORTER's Analysis
   4.2. Cancer Profiling Regulatory Senario

5. Global Cancer Profiling Market Analysis and Forecast
   5.1. Global Cancer Profiling Market Outlook
        5.1.1. Market Value Analysis & Forecast
   5.2. Global Cancer Profiling Market Analysis by Product Type
        5.2.1. Instruments
               5.2.1.1. Immunohistochemistry (IHC) Analyzers
               5.2.1.2. Fluorescence In situ Hybridization (FISH) Instruments
               5.2.1.3. PCR instruments
               5.2.1.4. DNA Sequencer
               5.2.1.5. Fragment Analyzer
        5.2.2. Consumables
               5.2.2.1. Reagents & Kits
               5.2.2.2. Other Ancillary (probes, holders etc.)
        5.2.3. Market Attractiveness Analysis by Product Type
   5.3. Global Cancer Profiling Market Analysis by Indication
        5.3.1. Breast Cancer
        5.3.2. Colorectal Cancer
        5.3.3. Ovarian Cancer
        5.3.4. Melanoma
        5.3.5. Kidney Cancer
        5.3.6. Lung Cancer (including NSCLC)
        5.3.7. Rare Cancers
        5.3.8. Market Attractiveness Analysis by Indication
   5.4. Global Cancer Profiling Market Analysis by End User
        5.4.1. Hospitals
        5.4.2. Diagnostic Centres
        5.4.3. Cancer Research Institutes
        5.4.4. Others
        5.4.5. Market Attractiveness Analysis by End User

6. North America Cancer Profiling Market Analysis
   6.1. Introduction
        6.1.1. North America Cancer Profiling Market Outlook
   6.2. North America Cancer Profiling Market Outlook
        6.2.1. Market Value (US$ Mn) Forecast and Analysis
        6.2.2. Country Wise Demand Assessment
               6.2.2.1. US Market Value Share
               6.2.2.2. Canada Market Value Share
   6.3. North America Cancer Profiling Market Analysis by Product Type
        6.3.1. Value (US$ Mn) Forecast by Product Type
        6.3.2. Y-o-Y Growth Comparison by Product Type
   6.4. North America Cancer Profiling Market Analysis by Indication
        6.4.1. Value (US$ Mn) Forecast by Indication
        6.4.2. Y-o-Y Growth Comparison by Indication
   6.5. North America Cancer Profiling Market Analysis by End User
        6.5.1. Value (US$ Mn) Forecast by End User
        6.5.2. Y-o-Y Growth Comparison by End User
   6.6. Market Attractiveness Analysis
   6.7. Heat Map Analysis
   6.8. Impact Assessment of Market Forces

7. Latin America Cancer Profiling Market Analysis
   7.1. Introduction
        7.1.1. Latin America Cancer Profiling Market Outlook
   7.2. Latin America Cancer Profiling Market Outlook
        7.2.1. Market Value (US$ Mn) Forecast and Analysis
        7.2.2. Country Wise Demand Assessment
               7.2.2.1. Brazil Market Value Share
               7.2.2.2. Mexico Market Value Share
               7.2.2.3. Rest of LATAM Market Value Share
   7.3. Latin America Cancer Profiling Market Analysis by Product Type
        7.3.1. Value (US$ Mn) Forecast by Product Type
        7.3.2. Y-o-Y Growth Comparison by Product Type
   7.4. Latin America Cancer Profiling Market Analysis by Indication
        7.4.1. Value (US$ Mn) Forecast by Indication
        7.4.2. Y-o-Y Growth Comparison by Indication
   7.5. Latin America Cancer Profiling Market Analysis by End User
        7.5.1. Value (US$ Mn) Forecast by End User
        7.5.2. Y-o-Y Growth Comparison by End User
   7.6. Market Attractiveness Analysis
   7.7. Heat Map Analysis
   7.8. Impact Assessment of Market Forces

8. Europe Cancer Profiling Market Analysis
   8.1. Introduction
        8.1.1. Europe Cancer Profiling Market Outlook
   8.2. Europe Cancer Profiling Market Outlook
        8.2.1. Market Value (US$ Mn) Forecast and Analysis
        8.2.2. Country Wise Demand Assessment
               8.2.2.1. EU -4 Market Value Share
               8.2.2.2. UK Market Value Share
               8.2.2.3. Benelux Market Value Share
               8.2.2.4. Nordic Market Value Share
               8.2.2.5. Rest of Europe Market Value Share
   8.3. Europe Cancer Profiling Market Analysis by Product Type
        8.3.1. Value (US$ Mn) Forecast by Product Type
        8.3.2. Y-o-Y Growth Comparison by Product Type
   8.4. Europe Cancer Profiling Market Analysis by Indication
        8.4.1. Value (US$ Mn) Forecast by Indication
        8.4.2. Y-o-Y Growth Comparison by Indication
   8.5. Europe Cancer Profiling Market Analysis by End User
        8.5.1. Value (US$ Mn) Forecast by End User
        8.5.2. Y-o-Y Growth Comparison by End User
   8.6. Market Attractiveness Analysis
   8.7. Heat Map Analysis
   8.8. Impact Assessment of Market Forces

9. CIS & Russia Cancer Profiling Market Analysis
   9.1. Introduction
        9.1.1. CIS & Russia Cancer Profiling Market Outlook
   9.2. CIS & Russia Cancer Profiling Market Outlook
        9.2.1. Market Value (US$ Mn) Forecast and Analysis
   9.3. CIS & Russia Cancer Profiling Market Analysis by Product Type
        9.3.1. Value (US$ Mn) Forecast by Product Type
        9.3.2. Y-o-Y Growth Comparison by Product Type
   9.4. CIS & Russia Cancer Profiling Market Analysis by Indication
        9.4.1. Value (US$ Mn) Forecast by Indication
        9.4.2. Y-o-Y Growth Comparison by Indication
   9.5. CIS & Russia Cancer Profiling Market Analysis by End User
        9.5.1. Value (US$ Mn) Forecast by End User
        9.5.2. Y-o-Y Growth Comparison by End User
   9.6. Market Attractiveness Analysis
   9.7. Heat Map Analysis
   9.8. Impact Assessment of Market Forces

10. Japan Cancer Profiling Market Analysis and Forecast
   10.1.Introduction
        10.1.1. Japan Cancer Profiling Market Outlook
   10.2.Japan Cancer Profiling Market Outlook
        10.2.1. Market Value (US$ Mn) Forecast and Analysis
   10.3.Japan Cancer Profiling Market Analysis by Product Type
        10.3.1. Value (US$ Mn) Forecast by Product Type
        10.3.2. Y-o-Y Growth Comparison by Product Type
   10.4.Japan Cancer Profiling Market Analysis by Indication
        10.4.1. Value (US$ Mn) Forecast by Indication
        10.4.2. Y-o-Y Growth Comparison by Indication
   10.5.Japan Cancer Profiling Market Analysis by End User
        10.5.1. Value (US$ Mn) Forecast by End User
        10.5.2. Y-o-Y Growth Comparison by End User
   10.6.Market Attractiveness Analysis
   10.7.Heat Map Analysis
   10.8.Impact Assessment of Market Forces

11. APEJ Cancer Profiling Market Analysis and Forecast
   11.1.Introduction
        11.1.1. APEJ Cancer Profiling Market Outlook
   11.2.APEJ Cancer Profiling Market Outlook
        11.2.1. Market Value (US$ Mn) Forecast and Analysis
        11.2.2. Country Wise Demand Assessment
               11.2.2.1. Greater China Market Value Share
               11.2.2.2. India Market Value Share
               11.2.2.3. ASEAN Market Value Share
               11.2.2.4. South Korea Market Value Share
               11.2.2.5. ANZ Market Value Share
               11.2.2.6. Rest of APEJ Market Value Share
   11.3.APEJ Cancer Profiling Market Analysis by Product Type
        11.3.1. Value (US$ Mn) Forecast by Product Type
        11.3.2. Y-o-Y Growth Comparison by Product Type
   11.4.APEJ Cancer Profiling Market Analysis by Indication
        11.4.1. Value (US$ Mn) Forecast by Indication
        11.4.2. Y-o-Y Growth Comparison by Indication
   11.5.APEJ Cancer Profiling Market Analysis by End User
        11.5.1. Value (US$ Mn) Forecast by End User
        11.5.2. Y-o-Y Growth Comparison by End User
   11.6.Market Attractiveness Analysis
   11.7.Heat Map Analysis
   11.8.Impact Assessment of Market Forces

12. MEA Cancer Profiling Market Analysis and Forecast
   12.1.Introduction
        12.1.1. MEA Cancer Profiling Market Outlook
   12.2.MEA Cancer Profiling Market Outlook
        12.2.1. Market Value (US$ Mn) Forecast and Analysis
        12.2.2. Country Wise Demand Assessment
               12.2.2.1. GCC Countries Market Value Share
               12.2.2.2. South Africa Market Value Share
               12.2.2.3. Turkey Market Value Share
               12.2.2.4. Rest of MEA Market Value Share
   12.3.MEA Cancer Profiling Market Analysis by Product Type
        12.3.1. Value (US$ Mn) Forecast by Product Type
        12.3.2. Y-o-Y Growth Comparison by Product Type
   12.4.MEA Cancer Profiling Market Analysis by Indication
        12.4.1. Value (US$ Mn) Forecast by Indication
        12.4.2. Y-o-Y Growth Comparison by Indication
   12.5.MEA Cancer Profiling Market Analysis by End User
        12.5.1. Value (US$ Mn) Forecast by End User
        12.5.2. Y-o-Y Growth Comparison by End User
   12.6.Market Attractiveness Analysis
   12.7.Heat Map Analysis
   12.8.Impact Assessment of Market Forces

13. Global Cancer Profiling Market Value (US$ Mn) and Volume (‘000 tests) Analysis, By Tests Type, 2017
   13.1.Introduction
   13.2.North America Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
        13.2.1. Immunohistochemistry (IHC)
        13.2.2. Fluorescence In situ Hybridization (FISH)
        13.2.3. Quantitative Polymerase Chain Reaction (qPCR)
        13.2.4. Next-Generation Sequencing (NGS)
        13.2.5. Sanger Sequencing
        13.2.6. Fragment Analysis
   13.3.Latin America Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.4.Europe Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.5.CIS & Russia Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.6.APEJ Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.7.Japan Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017
   13.8.MEA Cancer Profiling Tests Value (US$ Mn) & Volume (‘000 tests) Analysis, 2017

14. Competitive Assessment
   14.1.Global Cancer Profiling Market Competition - a Dashboard View
   14.2.Global Cancer Profiling Market Structure (2017)

15. Company Profiles
   15.1.Qiagen N.V.
        15.1.1. Geographical Footprint
        15.1.2. Regional Revenue
        15.1.3. Key Financials
        15.1.4. SWOT Analysis
   15.2.Roche Molecular Systems INC.
   15.3.Abbott Laboratories
   15.4.Siemens AG
   15.5.Neogenomics Laboratories
   15.6.Illumina, Inc.
   15.7.HTG Molecular Diagnostic
   15.8.PerkinElmer Inc.
   15.9.Genomic Health INC.
   15.10.Nanostring Technologies, Inc.
   15.11.BioGenex
   15.12.Thermo Fisher Scientific Inc.
   15.13.Pacific Biosciences
   15.14.Agilent Technologies, Inc.

16. Assumptions and Acronyms Used

17. Research Methodology

Table 01: Global Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region
Table 02: Global Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 03: Global Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 04: Global Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 05: North America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 06: North America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 07: North America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 08: North America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 09: Latin America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 10: Latin America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 11: Latin America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 12: Latin America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 13: Europe Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 14: Europe Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 15: Europe Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 16: Europe Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 17: CIS & Russia Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 18: CIS & Russia Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 19: CIS & Russia Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 20: Japan Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 21: Japan Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 22: Japan Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 23: APEJ Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 24: APEJ Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 25: APEJ Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 26: APEJ Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 27: MEA Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 28: MEA Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type
Table 29: MEA Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 30: MEA Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User
Table 31: Global Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 32: Global Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 33: North America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 34: North America Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 35: Latin America Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 36: Latin America Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 37: Europe Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 38: Europe Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 39: CIS & Russia Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 40: CIS & Russia Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 41: Japan Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 42: Japan Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 43: APEJ Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 44: APEJ Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 45: MEA Cancer Profiling Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Test Type
Table 46: MEA Cancer Profiling Market Volume (000’Units) Analysis 2013-2017 and Forecast 2018-2028, By Test Type

Figure 01: Cancer Profiling  Market Revenue Share by Product Type, 2018E & 2028F 
Figure 02: Cancer Profiling  Market Revenue Share by Indication  , 2018E & 2028F 
Figure 03: Cancer Profiling  Market Revenue Share by end users , 2018E & 2028F
Figure 04: Cancer Profiling Market Revenue Share by Region, 2018E & 2028F 
Figure 05: Wheel Of Fortune 
Figure 06: IHC Test  Pricing Analysis  (US$) By Region, 2017 (Per Unit)
Figure 07: FISH Pricing Analysis  (US$) By Region, 2017 (Per Unit)
Figure 08: qPCR Test Pricing Analysis  (US$) By Region, 2017 (Per Unit)
Figure 09: NGS  Pricing Analysis  (US$) By Region, 2017 (Per Unit)
Figure 10: Fragment Analysis Test Pricing Analysis  (US$) By Region, 2017 (Per Unit)
Figure 11: Sanger Sequencing Test Pricing Analysis  (US$) By Region, 2017 (Per Unit)
Figure 12: Global  Cancer Profiling Market, by Indication (2017)
Figure 13: Global Cancer Profiling Market, by Country (2017)
Figure 14:  Global Cancer Profiling Market, by End User (2017)
Figure 15: Global  Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 16: Global Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 17: North America Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 18: North America Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 19: Latin America Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 20: Latin America Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 21: Europe  Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 22: Europe Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 23: CIS & Russia  Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 24: CIS & Russia  Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 25: Japan Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 26: Japan  Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 27: APEJ Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 28: APEJ  Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 29: MEA Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 30: MEA Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 31: Global Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 32: Global  Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 33: Global Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 34: Global Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 35: North America Cancer Profiling Market Attractiveness Analysis, By Country
Figure 36: Global Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 37: Global  Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 38: North America Cancer Profiling Market Attractiveness Analysis, By End User
Figure 39: North America Cancer Profiling Market, by Product Type (2017)
Figure 40: North America Cancer Profiling Market, Snapshot
Figure 41: North America Cancer Profiling Market, by Indication (2017)
Figure 42: North America Cancer Profiling Market, by Country (2017)
Figure 43: North America Cancer Profiling Market, by End User (2017)
Figure 44: North America Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 45: North America Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 46: U.S. Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 47: U.S. Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 48: Canada Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 49: Canada Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 50: North America Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 51: North America Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 52: North America Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 53: North America Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 54: North America Cancer Profiling Market Attractiveness Analysis, By Country
Figure 55: North America Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 56: North America Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 57: North America Cancer Profiling Market Attractiveness Analysis, By End User
Figure 58: Latin America Cancer Profiling Market, by Product Type (2017)
Figure 59: Latin America Cancer Profiling Market, Snapshot
Figure 60: Latin America Cancer Profiling Market, by Indication (2017)
Figure 61: Latin America Cancer Profiling Market, by Country (2017)
Figure 62: Latin America Cancer Profiling Market, by End User (2017)
Figure 63: Latin America Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 64: Latin America Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 65: Brazil Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 66: Brazil Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 67: Mexico Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 68: Mexico Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 69: Rest of Latin America Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 70: Rest of Latin America Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 71: Latin America Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 72: Latin America Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 73: Latin America Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 74: Latin America Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 75: Latin America Cancer Profiling Market Attractiveness Analysis, By Country
Figure 76: Latin America Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 77: Latin America Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 78: Latin America Cancer Profiling Market Attractiveness Analysis, By End User
Figure 79: Europe Cancer Profiling Market, by Product Type (2017)
Figure 80: Europe Cancer Profiling Market, Snapshot
Figure 81: Europe Cancer Profiling Market, by Indication (2017)
Figure 82: Europe Cancer Profiling Market, by Country (2017)
Figure 83: Europe Cancer Profiling Market, by End User (2017)
Figure 84: Europe Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 85: Europe Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 86: EU-4 Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 87: EU-4 Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 88: U.K. Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 89: U.K. Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 90: Benelux Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 91: Benelux Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 92: Nordic Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 93: Nordic Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 94: Rest of Europe Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 95: Rest of Europe Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 96: Europe Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 97: Europe Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 98: Europe Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 99: Europe Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 100: Europe Cancer Profiling Market Attractiveness Analysis, By Country
Figure 101: Europe Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 102: Europe Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 103: Europe Cancer Profiling Market Attractiveness Analysis, By End User
Figure 104: CIS & Russia Cancer Profiling Market, by Product Type (2017)
Figure 105: CIS & Russia Cancer Profiling Market, Snapshot
Figure 106: CIS & Russia Cancer Profiling Market, by Indication (2017)
Figure 107: CIS & Russia Cancer Profiling Market, by End User (2017)
Figure 108: CIS & Russia Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 109: CIS & Russia Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 110: CIS & Russia Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 111: CIS & Russia Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 112: CIS & Russia Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 113: CIS & Russia Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 114: CIS & Russia Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 115: CIS & Russia Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 116: CIS & Russia Cancer Profiling Market Attractiveness Analysis, By End User
Figure 117: Japan Cancer Profiling Market, by Product Type (2017)
Figure 118: Japan Cancer Profiling Market, Snapshot
Figure 119: Japan Cancer Profiling Market, by Indication (2017)
Figure 120: Japan Cancer Profiling Market, by End User (2017)
Figure 121: Japan Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 122: Japan Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 123: Japan Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 124: Japan Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 125: Japan Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 126: Japan Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 127: Japan Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 128: Japan Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 129: Japan Cancer Profiling Market Attractiveness Analysis, By End User
Figure 130: APEJ Cancer Profiling Market, by Product Type (2017)
Figure 131: APEJ Cancer Profiling Market, Snapshot
Figure 132: APEJ Cancer Profiling Market, by Indication (2017)
Figure 133: APEJ Cancer Profiling Market, by Country (2017)
Figure 134: APEJ Cancer Profiling Market, by End User (2017)
Figure 135: APEJ Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 136: APEJ Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 137: Greater China Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 138: Greater China Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 139: India Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 140: India Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 141: ASEAN Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 142: ASEAN Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 143: South Korea Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 144: South Korea Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 145: Australia & New Zealand Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 146: Australia & New Zealand Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 147: Rest of APEJ Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 148: Rest of APEJ Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 149: APEJ Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 150: APEJ Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 151: APEJ Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 152: APEJ Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 153: APEJ Cancer Profiling Market Attractiveness Analysis, By Country
Figure 154: APEJ Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 155: APEJ Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 156: APEJ Cancer Profiling Market Attractiveness Analysis, By End User
Figure 157: MEA Cancer Profiling Market, by Product Type (2017)
Figure 158: MEA Cancer Profiling Market, Snapshot
Figure 159: MEA Cancer Profiling Market, by Indication (2017)
Figure 160: MEA Cancer Profiling Market, by Country (2017)
Figure 161: MEA Cancer Profiling Market, by End User (2017)
Figure 162: MEA Cancer Profiling Market Size (US$ Mn), 2013–2017
Figure 163: MEA Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028
Figure 164: GCC Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 165: GCC Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 166: South Africa Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 167: South Africa Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 168: Turkey Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017
Figure 169: Turkey Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 170: Rest of MEA Cancer Profiling Size (US$ Mn) Analysis, 2013–2017
Figure 171: Rest of MEA Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 172: MEA Cancer Profiling Market Size (US$ Mn) Analysis, 2013–2017, by Instruments 
Figure 173: MEA Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Instruments 
Figure 174: MEA Cancer Profiling Size (US$ Mn) Analysis, 2013–2017, by Consumables 
Figure 175: MEA Cancer Profiling Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Consumables 
Figure 176: MEA Cancer Profiling Market Attractiveness Analysis, By Country
Figure 177: MEA Cancer Profiling Market Attractiveness Analysis, By Product Type
Figure 178: MEA Cancer Profiling Market Attractiveness Analysis, By Indication
Figure 179: MEA Cancer Profiling Market Attractiveness Analysis, By End User
Figure 180: Global Cancer Profiling Market, by Test Type (2017)
Figure 181: Global Cancer Profiling Market, By Test Type, Snapshot
Figure 182: Global Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 183: Global Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type
Figure 184: North America Cancer Profiling Market, by Test Type (2017)
Figure 185: North America Cancer Profiling Market, By Test Type, Snapshot
Figure 186: North America Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 187: North America Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type
Figure 188: Latin America Cancer Profiling Market, by Test Type (2017)
Figure 189: Latin America Cancer Profiling Market, By Test Type, Snapshot
Figure 190: Latin America Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 191: Latin America Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type
Figure 192: Europe Cancer Profiling Market, by Test Type (2017)
Figure 193: Europe Cancer Profiling Market, By Test Type, Snapshot
Figure 194: Europe Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 195: Europe Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type
Figure 196: CIS & Russia Cancer Profiling Market, by Test Type (2017)
Figure 197: CIS & Russia Cancer Profiling Market, By Test Type, Snapshot
Figure 198: CIS & Russia Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 199: CIS & Russia Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type
Figure 200: Japan Cancer Profiling Market, by Test Type (2017)
Figure 201: Japan Cancer Profiling Market, By Test Type, Snapshot
Figure 202: Japan Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 203: Japan Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type
Figure 204: APEJ Cancer Profiling Market, by Test Type (2017)
Figure 205: APEJ Cancer Profiling Market, By Test Type, Snapshot
Figure 206: APEJ Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 207: APEJ Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type
Figure 208: MEA Cancer Profiling Market, by Test Type (2017)
Figure 209: MEA Cancer Profiling Market, By Test Type, Snapshot
Figure 210: MEA Cancer Profiling Market Size (US$ Mn), 2013–2017, By Test Type
Figure 211: MEA Cancer Profiling Market Size (US$) & Y-o-Y Growth (%), 2018–2028, By Test Type

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development